FEATURED COMPANIES
- Abbott
- Danaher Corporation
- Roche
- Siemens Healthineers
- Sysmex Corporation
- MORE
In-Vitro Diagnostic tests provide adequate information about the diseases without interacting directly to the human body. In-Vitro Diagnostic has numerous applications in disease diagnosing such as Infectious Diseases, Oncology, Diabetes, Cardiovascular diseases, and others. IVD is used by physicians and clinicians at the various stages of the patient care pathway in hospitals, laboratories or other healthcare settings. With the increasing disease burden, the number of diagnostic tests in Saudi Arabia is also increasing and so is the In Vitro Diagnostics market of Saudi Arabia. Saudi Arabia IVD Market is poised to reach US$ 700 Million by the year 2024.
With increasing cases of new strains of viruses and epidemic diseases, health experts are innovating unique healthcare solutions to improve the combat and cure for diseases. Among these innovations, In-vitro diagnostics plays a considerable role in saving people's lives by providing accurate diagnosis and prognosis, which further enables improved monitoring and treatment. Owing to the benefits offered by IVD, there is steady growth in its adoption and usage. Increasing incidences rates of infectious diseases and the lifestyle diseases are few factors, which are driving the Saudi Arabia In-Vitro Diagnostics (IVD) Market.
This report titled “Saudi Arabia In Vitro Diagnostics (IVD) Market, by Techniques [Immunochemistry, Clinical Chemistry, Hematology, Hemostasis, Microbiology, Molecular Diagnostic, Self Monitoring of Blood Glucose (SMBG) and Point of Care Testing (POCT)]; by Applications (Infectious Diseases, Cardiovascular Diseases, Oncology, Diabetes and others); By End User (Government Labs & Hospitals, Private Labs & Hospitals and others) and by Companies (Roche, Abbott, Siemens Healthineers, Sysmex Corporation and Danaher Corporation)” provides a complete analysis of Saudi Arabia In-Vitro Diagnostics (IVD) Market.
By Technique - Immunochemistry, Clinical Chemistry and SMBG Driving the Saudi Arabia In-Vitro Diagnostics (IVD) Market
The report studies the market of the following In-Vitro Diagnostics segments: Immunochemistry, Clinical Chemistry, Hematology, Hemostasis, Microbiology, Molecular Diagnostic, Self Monitoring of Blood Glucose (SMBG) and Point of Care Testing (POCT). Due to the rising infectious diseases, cancer cases and a number of diabetics in the Kingdom of Saudi Arabia, it is believed that Saudi Arabia IVD Market will grow effortlessly in the coming years.
By Application - Infectious Disease and Diabetes hold significant market of Saudi Arabia In-Vitro Diagnostics (IVD) Market
On the basis of applications; Saudi Arabia In-Vitro Diagnostics has been broadly segmented into Infectious Diseases, Cardiovascular Diseases, Oncology, Diabetes, and others.
By End User - Government Hospitals & Laboratory holds the Largest Market
The report studies the market of the following End-User segments: Government Labs & Hospitals, Private Labs & Hospitals, and others.
Companies Analysis
Roche, Abbott, Siemens Healthineers, Sysmex Corporation, and Danaher Corporation are some of the top companies operating in the In-Vitro Diagnostics; has been studied thoroughly in the report.
This market research report provides a complete analysis of the Saudi Arabia In-Vitro Diagnostics (IVD) Market, Growth Drivers, Challenges, and their projections for the upcoming years.
By Technique
- Immunochemistry
- Clinical Chemistry
- Hematology
- Hemostasis
- Microbiology
- Molecular Diagnostic
- Self Monitoring of Blood Glucose (SMBG)
- Point of Care Testing (POCT)
By Application
- Infectious Diseases
- Cardiovascular Diseases
- Diabetes
- Oncology
- Others
By End User
- Government Labs & Hospitals
- Private Labs & Hospitals
- Others
Companies
- Roche
- Abbott
- Siemens Healthineers
- Sysmex Corporation
- Danaher Corporation
FEATURED COMPANIES
- Abbott
- Danaher Corporation
- Roche
- Siemens Healthineers
- Sysmex Corporation
- MORE
1. Introduction
2. Research Methodology
3. Executive Summary
4. Saudi Arabia
4.1 Population
4.2 Per Capita Healthcare Expenses
4.3 Healthcare Expenditure
5. Saudi Arabia IVD Market (2011-2024)
6. Market Share - Saudi Arabia In Vitro Diagnostics (IVD) (2011 - 2024)
6.1 By Segments
6.2 By Disease
7. Segments - Saudi Arabia IVD Market (2011- 2024)
7.1 Immunochemistry Market
7.2 Clinical Chemistry Market
7.3 Hematology Market
7.4 Hemostasis/Coagulation Market
7.5 Microbiology Market
7.6 Molecular Diagnostic Market
7.7 Self Monitoring of Blood Glucose (SMBG) Market
7.8 Point of Care Testing (POCT) Market
8. Disease - Saudi Arabia IVD Market (2011- 2024)
8.1 Infectious
8.2 Cardiovascular
8.3 Diabetes
8.4 Oncology
8.5 Others
9. End User - Saudi Arabia IVD Market (2011- 2024)
9.1 Public Labs & Hospitals
9.2 Private Labs & Hospitals
10. Company Analysis
10.1 Roche Diagnostics
10.1.1 Overview
10.1.2 Company Initiatives
10.1.3 Sales Analysis
10.2 Abbott
10.2.1 Overview
10.2.2 Company Initiatives
10.2.3 Sales Analysis
10.3 Siemens Healthineers
10.3.1 Overview
10.3.2 Company Initiatives
10.3.3 Sales Analysis
10.4 Sysmex Corporation
10.4.1 Overview
10.4.2 Company Initiatives
10.4.3 Sales Analysis
10.5 Danaher Corporation
10.5.1 Overview
10.5.2 Company Initiatives
10.5.3 Sales Analysis
List of Figures:
Figure-01: Saudi Arabia - IVD Market size (Million US$), 2018 & 2024
Figure-02: Saudi Arabia - IVD Market by Growing Diseases
Figure-03: Saudi Arabia Population (Million), 2011 - 2018
Figure-04: Forecast for Saudi Arabia Population (Million), 2019 - 2024
Figure-05: Saudi Arabia Per Capita Healthcare Expenses, 2011 - 2017
Figure-06: Saudi Arabia Healthcare Expenditure (Billion US$), 2011 - 2017
Figure-07: Saudi Arabia IVD Market (Million US$), 2011 - 2018
Figure-08: Forecast for Saudi Arabia IVD Market (Million US$), 2019 - 2024
Figure-09: Saudi Arabia IVD Market Share by Segments (Percent), 2011 - 2018
Figure-10: Forecast for Saudi Arabia IVD Market Share by Segments (Percent), 2011 - 2018
Figure-11: Saudi Arabia - Immunochemistry Market (Million US$), 2011 - 2018
Figure-12: Saudi Arabia - Forecast for Immunochemistry Market (Million US$), 2019 - 2024
Figure-13: Saudi Arabia - Clinical Chemistry Market (Million US$), 2011 - 2018
Figure-14: Saudi Arabia - Forecast for Clinical Chemistry Market (Million US$), 2019 - 2024
Figure-15: Saudi Arabia - Hematology Market (Million US$), 2011 - 2018
Figure-16: Saudi Arabia - Forecast for Hematology Market (Million US$), 2019 - 2024
Figure-17: Saudi Arabia - Hemostasis/Coagulation Market (Million US$), 2011 - 2018
Figure-18: Saudi Arabia - Forecast for Hemostasis/Coagulation Market (Million US$), 2019 - 2024
Figure-19: Saudi Arabia - Microbiology Market (Million US$), 2011 - 2018
Figure-20: Saudi Arabia - Forecast for Microbiology Market (Million US$), 2019 - 2024
Figure-21: Saudi Arabia - Molecular Diagnostic Market (Million US$), 2011 - 2018
Figure-22: Saudi Arabia - Forecast for Molecular Diagnostic Market (Million US$), 2019 - 2024
Figure-23: Saudi Arabia - Self Monitoring of Blood Glucose (SMBG) Market (Million US$), 2011 - 2018
Figure-24: Saudi Arabia - Forecast for Self Monitoring of Blood Glucose (SMBG) Market (Million US$), 2019 - 2024
Figure-25: Saudi Arabia - Point of Care Testing (POCT) Market (Million US$), 2011 - 2018
Figure-26: Saudi Arabia - Forecast for Point of Care Testing (POCT) Market (Million US$), 2019 - 2024
Figure-27: Saudi Arabia - Infectious Disease Market (Million US$), 2011 - 2018
Figure-28: Saudi Arabia - Forecast for Infectious Disease Market (Million US$), 2019 - 2024
Figure-29: Saudi Arabia - Cardiovascular Disease Market (Million US$), 2011 - 2018
Figure-30: Saudi Arabia - Forecast for Cardiovascular Disease Market (Million US$), 2019 - 2024
Figure-31: Saudi Arabia - Diabetes Market (Million US$), 2011 - 2018
Figure-32: Saudi Arabia - Forecast for Diabetes Market (Million US$), 2019 - 2024
Figure-33: Saudi Arabia - Oncology Market (Million US$), 2011 - 2018
Figure-34: Saudi Arabia - Forecast for Oncology Market (Million US$), 2019 - 2024
Figure-35: Saudi Arabia - Other Disease Market (Million US$), 2011 - 2018
Figure-36: Saudi Arabia - Forecast for Other Disease Market (Million US$), 2019 - 2024
Figure-37: Saudi Arabia - End User Market by Public Labs (Million US$), 2011 - 2018
Figure-38: Saudi Arabia - Forecast for End User Market by Public Labs (Million US$), 2019 - 2024
Figure-39: Saudi Arabia - End User Market by Private Labs (Million US$), 2011 - 2018
Figure-40: Saudi Arabia - Forecast for End User Market by Private Labs (Million US$), 2019 - 2024
Figure-41: Saudi Arabia - End User Market by Other Labs (Million US$), 2011 - 2018
Figure-42: Saudi Arabia - Forecast for End User Market by Other Labs (Million US$), 2019 - 2024
Figure-43: KSA Insurance Market (in SAR Million) 2007 - 2015
Figure-44: Total Population in KSA in Million
Figure-45: Percentage share of Population over 60 years old
Figure-46: Countries with Highest Hypertension Prevalence Rate in MENA Regions (2014)
Figure-47: Countries with Highest Diabetes Prevalence Rate in MENA Region (2014)
Figure-48: Rising Cigar Import - 2010 - 2013
Figure-49: Percentage Split of Healthcare services in KSA 2014
Figure-50: Percentage Split of Laboratory services in KSA 2014
Figure-51: Roche Diagnostics - Global Sales (Billion US$), 2011 - 2018
Figure-52: Roche Diagnostics - Global Sales Forecast (Billion US$), 2019 - 2024
Figure-53: Abbott - Global Diagnostics Sales (Million US$), 2011 - 2018
Figure-54: Abbott - Forecast Global Diagnostics Sales (Million US$), 2019 - 2024
Figure-55: Siemens Healthineers - Net Sales (Million US$), 2011 - 2018
Figure-56: Siemens Healthineers - Forecast for Net Sales (Million US$), 2019 - 2024
Figure-57: Sysmex Corporation - Net Sales (Million US$), 2011 - 2018
Figure-58: Sysmex Corporation - Forecast for Net Sales (Million US$), 2019 - 2024
Figure-59: Danaher Corporation - Global Diagnostics Sales (Million US$), 2011 - 2018
Figure-60: Danaher Corporation - Forecast Global Diagnostics Sales (Million US$), 2019 - 2024
- Abbott
- Danaher Corporation
- Roche
- Siemens Healthineers
- Sysmex Corporation
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
